Stay Connected. Stay Informed.
According to Natco Pharma, during the April-June quarter this year, the business faced pricing pressure in the U.S. product portfolio and the company incurred increased R&D expenses on account of high value projects. File | Photo Credit: Reuters Generic drugmaker Natco Pharma reported consolidated net profit for the June quarter declined more than 28% to…
Generic drugmaker and biotech company Laurus Labs reported consolidated net profit for June quarter surged to ₹163 crore from ₹13 crore year earlier. The higher net profit came on a 31% increase in revenue from operations to ₹1,570 crore (₹1,195 crore). Founder and CEO Satyanarayana Chava attributed the performance to increasing contributions from CDMO business…
Read More “Laurus Labs Q1 net surges to ₹163 cr on higher revenue” »
